UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000027404
Receipt number R000031382
Scientific Title A cohort study of the target protein as a novel tumor marker for patients with ovarian clear cell carcinoma befor or after surgery.
Date of disclosure of the study information 2017/07/01
Last modified on 2017/08/29 16:05:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A cohort study of the target protein as a novel tumor marker for patients with ovarian clear cell carcinoma befor or after surgery.

Acronym

A cohort study of a novel ovarian CCC tumor marker

Scientific Title

A cohort study of the target protein as a novel tumor marker for patients with ovarian clear cell carcinoma befor or after surgery.

Scientific Title:Acronym

A cohort study of a novel ovarian CCC tumor marker

Region

Japan


Condition

Condition

Ovarian clear cell carcinoma

Classification by specialty

Obstetrics and Gynecology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

We examine complementarity and subsidiarity of the target protein and CA125 measurement at the time of the follow-up from pre to post-operation.

Basic objectives2

Others

Basic objectives -Others

Practical clinical use of the target protein as a novel serum tumor marker

Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase



Assessment

Primary outcomes

Changes in serum levels of target protein and CA125 before and after surgery(every 1-3 month)

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1. Patinets whose pre-treatment serum samples are obetained.
2.Patients who submitted the documment for written informed consent

Key exclusion criteria

1. Patients who are judged as being inappropriate for this study.
2. Patients during pregnancy

Target sample size

15


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yusuke Kunimi

Organization

Kochi Health Science Center

Division name

Gynecology

Zip code


Address

2125-1, Ike, Kochi-city, Kochi-pref

TEL

088-837-3000

Email

yuusuke_kunimi@khsc.or.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yusuke Kunimi

Organization

Kochi Health Science Center

Division name

Gynecology

Zip code


Address

2125-1, Ike, Kochi-city, Kochi-pref

TEL

088-837-3000

Homepage URL


Email

yuusuke_kunimi@khsc.or.jp


Sponsor or person

Institute

Kochi Health Science Center

Institute

Department

Personal name



Funding Source

Organization

Tosoh Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

高知医療センター(高知県)


Other administrative information

Date of disclosure of the study information

2017 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2017 Year 08 Month 29 Day

Date of IRB


Anticipated trial start date

2017 Year 09 Month 15 Day

Last follow-up date

2018 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Samples will be analyzed accrodingly.


Management information

Registered date

2017 Year 05 Month 19 Day

Last modified on

2017 Year 08 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031382


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name